SLC7A11 and ovarian carcinoma: It has been found that the overexpression of Ets-1 in the human ovarian carcinoma cell line 2008 decreased intracellular ROS and increased intracellular GSH, GPX antioxidant activity, and SLC7A11 expression and activity.